Kalaris Therapeutics offers differentiated approach to neovascular AMD with its lead candidate TH103. Click here to read my ...

SIGLEC Phase 2b data support AVD-104 as a potential therapy to reduce GA lesion growth, preserve and improve visual acuity, and reduce conversion to neovascular AMD across all GA lesion types at 1 ...

Migraine is often minimized as simple pain, but we must treat it as a complex neurological cascade involving cortical ...

Twisted graphene heterostructures detect temperature with 99% accuracy, reduce thermal image errors by 46%, and execute logic ...

Understanding the surprising mechanism behind apathy can help unlock scientific ways to boost your motivation ...

Malaria mosquitoes track humans by scent, not random flight, revealing why some people are bitten more at night.

The immunotherapies used to treat melanoma now include well-established drugs such as Keytruda (pembrolizumab) and Opdivo (nivolumab) and newer ones such as Amtagvi (lifileucel), which uses T cells ...

Globant, a digitally native company that helps organizations thrive in a digital and AI-powered future, today released its latest report, "Tech Trends 2026: The 5 Forces Shaping the Future." The study ...

TUCSON, AZ / ACCESS Newswire / December 8, 2025 / Umbrella Labs today announced the launch of its research-use-only MK-677 (Ibutamoren, Nutrobal) program, built around a liquid formulation and an ...

Have you ever sat quietly in a chair, attempting to relax, only to be interrupted by a sudden itch on your foot or a tingling ...

The U.S. FDA assigned a target action date of April 8, 2026PRINCETON, N.J.--(BUSINESS WIRE)--$BMY #FDA--Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA ...

Scientists have finally watched influenza viruses break into living human cells in real time, catching the microscopic ...